| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.6337 | 50 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.3922 | 15 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.216 | 33 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.1537 | 42 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.0482 | 13 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.7846 | 12 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 52.8562 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.0569 | 13 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.2884 | 24 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.9296 | 13 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.1196 | 45 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.393 | 29 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 51.4173 | 53 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.0745 | 18 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.7439 | 40 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.4666 | 24 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.8833 | 22 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.2889 | 33 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.0373 | 18 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.0516 | 54 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.2311 | 23 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.71 | 48 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.0612 | 41 |